Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DiaSorin S.p.A. (IT:DIA)
MILAN:DIA
Holding IT:DIA?
Track your performance easily
DIA Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€82.72 - €112.35
Previous Close€107.45
Volume45.02K
Average Volume (3M)112.64K
Market Cap
€5.88B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)35.0
Beta0.62
Next Earnings
Mar 12, 2025EPS Estimate
€1.09Last Dividend Ex-Date
May 20, 2024Dividend Yield1.08%
Share Statistics
EPS (TTM)3.07
Shares OutstandingN/A
10 Day Avg. Volume119,852
30 Day Avg. Volume112,644
Standard Deviation0.12
R-Squared0.00480
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)4.11
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€100.33Price Target Upside-6.43% Downside
Rating ConsensusHold
Number of Analyst Covering3
DiaSorin S.p.A. News
PremiumCompany Announcements
DiaSorin S.p.A. Boosts 2024 Revenue Guidance Amid Strong Growth
PremiumPre-Earnings
Is 0GZX a Buy, Before Earnings?
PremiumPre-Earnings
Is 0GZX a Buy, Before Earnings?Options Prices
Currently, No data available
---
Ownership Overview
12.49% Insiders
6.75% Mutual Funds
― Other Institutional Investors
77.24% Public Companies and
Individual Investors
DIA FAQ
What was DiaSorin S.p.A.’s price range in the past 12 months?
DiaSorin S.p.A. lowest stock price was €82.72 and its highest was €112.35 in the past 12 months.
What is DiaSorin S.p.A.’s market cap?
Currently, no data Available
When is DiaSorin S.p.A.’s upcoming earnings report date?
DiaSorin S.p.A.’s upcoming earnings report date is Mar 12, 2025 which is in 107 days.
How were DiaSorin S.p.A.’s earnings last quarter?
DiaSorin S.p.A. released its earnings results on Nov 05, 2024. The company reported €0.95 earnings per share for the quarter, beating the consensus estimate of €0.882 by €0.068.
Is DiaSorin S.p.A. overvalued?
According to Wall Street analysts DiaSorin S.p.A.’s price is currently Overvalued.
Does DiaSorin S.p.A. pay dividends?
DiaSorin S.p.A. pays a Annually dividend of €1.15 which represents an annual dividend yield of 1.08%. See more information on DiaSorin S.p.A. dividends here
What is DiaSorin S.p.A.’s EPS estimate?
DiaSorin S.p.A.’s EPS estimate is €1.09.
How many shares outstanding does DiaSorin S.p.A. have?
DiaSorin S.p.A. has 55,948,257 shares outstanding.
What happened to DiaSorin S.p.A.’s price movement after its last earnings report?
DiaSorin S.p.A. reported an EPS of €0.95 in its last earnings report, beating expectations of €0.882. Following the earnings report the stock price went up 0.895%.
Which hedge fund is a major shareholder of DiaSorin S.p.A.?
Currently, no hedge funds are holding shares in IT:DIA
---
DiaSorin S.p.A. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€100.33 (-6.43% Downside)
€100.33 (-6.43% Downside)
Insider Transactions
Sold Shares
Worth €13.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.13%
12-Months-Change
Fundamentals
Return on Equity
10.78%
Trailing 12-Months
Asset Growth
-2.47%
Trailing 12-Months
Company Description
DiaSorin S.p.A.
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics--testing done on samples taken from the human body, such as blood and issue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (77% of sales) and molecular diagnostics (14%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute the remaining 9% of total sales, DiaSorin has a strong presence in Europe, the Middle East, and Africa; the region accounts for the largest portion of company revenue (46%), followed by North America (29%), Asia-Pacific (19%), and Latin America (6%).
---
DIA Stock 12 Month Forecast
Average Price Target
€100.33
▼(-6.43% Downside)
Technical Analysis
HUTCHMED (China) Limited
―
Smith & Nephew
―
GlaxoSmithKline
―
AstraZeneca
―
DiaSorin S.p.A.
―
Best Analysts Covering DIA
1 Year
1 Year Success Rate
7/19 ratings generated profit
1 Year Average Return
-4.38%
reiterated a sell rating 20 days ago
Copying Maja Pataki's trades and holding each position for 1 Year would result in 36.84% of your transactions generating a profit, with an average return of -4.38% per trade.
---